List of top English Questions

Answer the question based on the passage given below.
Nearly two thousand years have passed since a census decreed by Caesar Augustus became part of the greatest story ever told. Many things have changed in the intervening years. The hotel industry worries more about overbuilding than overcrowding, and if they had to meet an unexpected influx, few inns would have managed to accommodate the weary guests. Now it is the census taker that does the travelling in the fond hope that a highly mobile population will stay put long enough to get a good sampling. Methods of gathering, recording and evaluating information have presumably been improved a great deal. And where then it was the modest purpose of Rome to obtain a simple head count as an adequate basis for levying taxes, now batteries of complicated statistical series furnished by governmental agencies and private organizations are eagerly scanned and interpreted by sages and seers to get a clue for future events.
The Bible does not tell us how the Roman census takers made out, and as regards our more immediate concern, the reliability of present-day economic forecasting, there are considerable differences of opinion. They were aired at the celebration of the 125th anniversary of the American Statistical Association. There was the thought that business forecasting might well be on its way from an art to a science, and some speakers talked about new-fangled computers and high-faulting mathematical systems in terms of excitement and endearment, which we, at least in our younger years when these things mattered, would have associated more readily with the description of a fair maiden.
But others pointed to a deplorable record of highly esteemed forecasts and forecasters with a batting average below that of the Mets and the President-elect of the Association cautioned that “high-powered statistical methods are usually in order where the facts are crude and inadequate, statisticians assume.” We left his birthday party somewhere between hope and despair and with the conviction, not really newly acquired, that proper statistical methods applied to ascertainable facts have their merits in economic forecasting as long as neither forecaster nor public is deluded into mistaking the delineation of probabilities and trends for a prediction of certainties of mathematical exactitude.
Answer the question based on the passage given below.
Rajendra K. Pachauri, head of the Intergovernmental Panel on Climate Change, is getting nightmares because of the Nano, Tata’s soon - to - be - launched Rs. One lakh car. Sunita Narain of the Centre for Science and Environment (CSE) says that it isn’t the Nano by itself but cars overall that give her nightmares. The villains in my nightmares are neither the Nano nor cars overall, but stupid government policies that subsidize and encourage pollution, adulteration and congestion.
Sanctimonious greens call the Nano disastrous because of its affordability - millions more will now clog roads and consume more fossil fuel. This is elitism parading as virtue. Elite greens own cars, but cannot stand the poorer masses becoming mobile, since the consequent congestion will eat into the time of the elite!
More logical would be a protest against big cars that use more space and fuel, or highly polluting old cars. Instead, green hypocrites aim at a new car with the lowest cost, best mileage and least emissions. The Nano will not burden us with too many cars. India has very few cars per person by world standards. London and New York have ultra-high car densities, yet have clearer air than Delhi. Our problem is too many bad policies, not too many cars.
We subsidize vehicles on a gargantuan scale invisible to lay folk. Roads and flyovers cost crores to build and maintain, yet road use is free (save on a few toll roads). Traffic police and lights are costly, yet are provided free. These invisible subsidies starve cities of funds to expand roads and public transport. Land in cities now costs lakhs per square metre. Yet parking is free in the suburbs, and often costs just Rs. 10 day per day in city centres. A single parking space of 23 square meters occupies land worth Rs. 40 lakhs. A car occupies more space than an office desk, yet the desk space pays full commercial rent while parking space costs just about Rs. 10 per day.
Daily parking charges range from $30 (Rs. 630) in Washington to $30 (Rs. 1260) in New York. CSE launched a sensible campaign to raise parking fees in Delhi to Rs. 120 per day, but was foiled. So, parking space now exceeds green space, a scathing comment on priorities.
The world price of crude oil has risen 13 fold since 1998 to over $139 per barrel, but Indian petrol prices have barely doubled. Left Front politicians, who once wanted to soak the rich, now want to subsidize them. Under-recoveries of oil companies’ total may be Rs. 2,00,000 crore, even after a recent price hike. This is far more than the cost of Sarva Shiksha Abhiyan (education for all) and the Employment Guarantee Scheme put together.
We sanctimoniously lecture rich countries to reduce their green house emissions, yet subsidize our own. Diesel is subsidized to be cheaper than petrol. So, Indian car makers produce the highest proportion of diesel cars in the world. Diesel fumes contain suspended particles that are highly toxic. This subsidy kills.
So does kerosene provided at throwaway prices, ostensibly to benefit poor villagers. One third of all kerosene is used to adulterate petrol and diesel. This causes horrendous pollution even in the greenest of cars.
What’s the way forward? We must abolish subsidies and raise taxes on vehicles and fuels to reflect their full social cost. The biggest but least visible subsidy is for parking, and we should start there.
Many car owners in the West take public transport to work since parking space downtown is costly and scarce. We should levy parking fees on an hourly, not daily, basis. Rs. 10 per hour could be a starting point in the metros.
In parts of Tokyo, you cannot own a car unless you own a private parking space. This is too extreme for India, but indicates the future path. If we charge owners the full social cost of parking, people will buy smaller and perhaps fewer vehicles, and fewer still will take them to work. That will slash congestion and pollution.
Cities should levy stiff annual taxes on vehicles, not a one-time tax, and use the revenue to constantly expand public transport and roads. This will create economic synergy: Private transport will finance public transport. London and New York have high density public transport as well as high car density.
Apart from underground rail, cities need elevated roads to ease congestion and pollution. Lata Mangeshkar helped kill a proposal for an elevated
road near her Mumbai flat: perhaps she felt her throat and singing would be affected. She did not care that the throats of poor people living on the pavements were far worse affected by fumes, and might get relief if some fumes were diverted to a higher level. What elitism!
Next, some medicine that will be really bitter, politically. The excise duty on all automotive vehicles should be raised to reflect their social costs. Fuel subsidies should be abolished. Price differentials between petrol, diesel and kerosene should be removed, ending incentives for adulteration. Diesel cars should bear a heavy additional cess to finance improved healthcare for those affected by their emission of harmful
particulate matter.
That is a long, politically difficult agenda. Only part of it will ever be achieved. Yet that is the way to go, rather than agitate the Nano.
Read the edited excerpt of an article by NELSON VINOD MOSES and answer the questions in this context. A successful non-resident Indian employed in the United States returns to a backward Indian village and transforms the lives of the villagers. Sounds familiar? At 31, Ashwin Naik is pacing through the path Shah Rukh Khan traced in his off-bear Bollywood movie, Swades. Naik had just quit his cushy job in a genomics firm in the US to join MIT Sloan School of Business. With a month in hand, he headed home a travelled through the remote areas of Bagalkot district in Karnataka. The woeful social conditions he saw moved him. Naik chucked the MBA course and in six months set up Vaatsalya Healthcare, a rural healthcare delivery system. In February 2005, Vaatsalya’s first hospital opened in Hubli. Two more centres were opened in Gadag and Karwar to offer specialist services of surgeons and facilities such as physiotherapy for children suffering from cerebral palsy. “We introduced paediatric surgery for infants below six months,” says Naik. “Else, patients would have to be taken to distant cities of Hubli or Bangalore.” Naik plans 100 more units in five states in the next three years. Mere charity by an affluent, middle-class professional? Far from it. Vaatsalya is one among rapidly spreading ‘for profit’ social enterprises that serve the poor and bring in profit. Mumbai-based Ziqitza, an imbalance services company, is another. It never refuses a patient for money, and charges Rs. 50 to 200. Done fleetingly in India and elsewhere till now, entrepreneurial minds with a social conscience are methodically creating such models at a greater pace. “There has been a boom in the past two years,” says Varun Sahni, country director of Acumen Fund, a US- based social fund that invests in companies that target low income communities. “Currently, there are about 1,000 in India.” The timing seems perfect. There is a wide market acceptance and funding has been coming in easily. These enterprises work across a swathe of areas including healthcare, education, rural energy, agriculture, arts and crafts, banking and more. ‘For profit’ entrepreneurs are obsessed with social and environmental impact in addition to the financial returns. Since they are answerable to the investors, they try expanding the business rapidly. SKS Microfinance, for instance, started in 1998 and has now over 900,000 customers, 440 branches and an outstanding loan disbursement of over Rs. 452 crores as of August 2007
Read the following passage and answer within its context.
TRIPs agreement provides a comprehensive set of global trade rules for the protection of copyright patents, trademarks, industrial designs, trade secrets, semiconductor lay out designs, and geographical indications, that apply to all the number-countries irrespective of their levels of development, natural and human endowments and history. Every member-country has been asked by the WTO to amend its national patent law to confirm to that universal globalized format for legislation relating to pharmaceutical, agrochemical, food, alloys, etc. Under Article 65, the developed countries have been asked to change their laws within another five years, and the less developed countries within an additional five years. The least developed countries have been asked to make those changes by 2005 AD. This attempt at global standardisation and uniformity by way of TRIP’s agreement is in conflict with the main thrust of the Rio Earth Summit of 1992 that set out the conditions for sustainable development. These two reveal two contrasting types of international approaches and norms. While the 1992 Earth Summit and the 1993 convention on biodiversity (CBD) focused on ‘diversity’ as being fundamental to sustain life and development, TRIPs and WTO are pushing for ‘conformity’ to international standardized norms on patents, services, labour, investment and what not irrespective of their history, ecology, level of economic development, etc. But despite their diametrically opposed viewpoints, 170 countries signed CBD upholding the need for diversity, and 50 countries signed the TRIPs agreement in 1994 claiming the urgency of uniformity, with a very large element of common names (130) in both. The convention on bio-diversity (CBD) in its Article 16.5 specifically asserts that intellectual property right must not be in conflict with conservation and sustainable use of bio-diversity, a provision that has been totally ignored by those who composed the TRIPs agreement. While in case of agriculture the higher yield of patented products induces the farmers to switch form a more varied production pattern, the resulting narrowing of genetic base makes the economy and society more vulnerable to plant disease and epidemics. It is true that the move towards cultivation of a smaller number of higher yielding varieties and the uniform spread of the same variety over a large space predates the present debate on patent, particularly since the introduction of the green revolution technology in the mid-sixties, but there can be no doubt that the latter has brought about a qualitative change in the scenario and has created possibility of a vast quantitative change too in that direction. So far no attempt has been made to reconcile the two conflicting approaches of CBD and TRIPs. If diversity is so important for sustaining life, how can WTO demand conformity to standardised global formats?
The following is an excerpt from a recent article by David Ewing Duncan. Read the passage and answer the questions within its context.
Eye surgeon Virendar Sangwan has perfected a procedure so cutting-edge that most who have tried it have failed. In an operating theatre in the central Indian city of Hyderabad, he surgically implants corneas grown in a petri dish from stem cells by his colleague Geeta Vemuganti in patients with damaged eyes. Together they perform about 80 corneal regeneration procedures a year, making the L.V. Prasad Eye Institute, where they work, one of the most prolific facilities in the world using stem cells to regenerate tissues of any kind. The Sangwan-Vemuganti team uses stem cells found in the tissues of living adults, not ones derived from embryos. Teams all over the world are working with adult stem cells, trying to coax them to regrow cells in hearts, brains, livers and other organs, but progress is slow. Besides corneas, scientists have had some success regrowing skin cells and bone tissues, but those procedures remain experimental. “A number of programs around the world have tried to perfect this treatment, but they have had bad outcomes,” says University of Cincinnati eye surgeon and stem cell specialist Edward Holland. “It is impressive what they are doing at Prasad.” In addition to the Hyderabad project, only Holland’s program and a half-dozen others in the world conduct operations using corneas grown from stem cells.The treatment uses stem cells harvested from the limbus, located where the cornea touches the white of the eye. For those with damaged corneas, these cells - called “limbic” and “conjunctiva” - are harvested from a patients good eye, if he has one, or from a close relative. They are placed in a petri dish and chemically tweaked to grow into the lower layer of a cornea, called epithelium. It is then transplanted into the eye of the patient where in most cases it takes hold and grows. In 56% of the cases at the Prasad Institute, patient could still see clearly after 40 months later.
Indians are well known for reverse engineering, meaning they can deduce how drugs are made in order to produce generic versions. But in this case, Sangwan and Vemuganti, a pathologist, developed the technique on their own from reading papers and running experiments in the lab. Sangwan says he had a number of patients with burned eyes who could not helped with standard corneal transplants from cadavers, so he persuaded Vemuganti to try growing corneas in her lab. “You know how to grow cells, and I know how to do the transplant surgery.” Vemuganti recalls him saying. “Why don’t we work together?” She smiles and shakes her head. “I had no clue if this was going to work.” Vemuganti’s major innovation was developing a platform on which to grow corneas. First she designed a circular glass tube about the size of a stack of coins. Then she overlaid the glass with tissue from a human placenta which is “a good surface to grow corneas on.” She says. After that she placed stem cells in four places around a circle, added a growth medium, and watched the corneas begin to grow. Commercial interests among stem cell companies for the procedure has been scant because of the perceived small volume of patients, says venture capitalist Antoun Nabhan of ay Capital, who sits on the board of Cellerant, a leading stem cell company in San Carlos. Calif. But corneal stem cell treatment may have wider applications, say ophthalmologist Ivan Schwab of University of California at Davis. “These stem cells are similar to others in the body that make mucous membrane,” he say. “These techniques of growing stem cells might one day be used to treat mucous-membrane tissue in the sinuses, bladder, and other organs.”